May 19-22, 2015

At IBC's 6th Annual Biosimilars Asia Meeting, key industry players currently featured in headlines will convene at the Grand Hyatt Shanghai May 19-22 2015 to showcase their success factors and directions they are steering in the forth coming years.

Here is a glimpse of the key topics to be addressed at the event:
- Key Criteria in Developing and Gaining Approval in Biosimilars 
- Finding Symbiotic Partnerships to Accelerate Biosimilars Market Launches 
- Biosimilars Clinical Trials Development: Key Considerations in Planning and Execution

- How to Develop a Biosimilar under CFDA Biosimilar Guideline 
- [Panel Discussion] Risks and Opportunities in Biosimilars/Biobetters and Key Enablers for Advancement